home / stock / qnrx / qnrx news

QNRX News and Press, Quoin Pharmaceuticals Ltd. From 07/24/23

Stock Information
Company Name: Quoin Pharmaceuticals Ltd.
Stock Symbol: QNRX
Market: NASDAQ
Website: quoinpharma.com
Menu
QNRX QNRX Quote QNRX Short QNRX News QNRX Articles QNRX Message Board
Get QNRX Alerts

News, Short Squeeze, Breakout and More Instantly...
QNRX - NKLA, XPO and DWAC among pre-market losers

2023-07-24 08:34:47 ET Kodiak Sciences ( KOD ) -53% announces topline results from its phase 3 Studies of tarcocimab tedromer in Neovascular age-related macular degeneration and diabetic macular edema. Contango Ore ( CTGO ) -25% . 22nd Century Group ( XXII ...
QNRX - XXII, GP and ACGN among mid-day movers

2023-07-21 13:09:38 ET Gainers: Digital World Acquisition Corp. ( DWAC ) +47% . Quoin Pharmaceuticals ( QNRX ) +46% . 22nd Century Group ( XXII ) +41% . Guardforce AI Co ( GFAI ) +28% . Biodexa Pharmaceuticals Plc ( BDRX ) +25% ....

QNRX - Quoin, Evelo top healthcare gainers; RedHill, BioSig among losers

2023-07-21 10:22:31 ET Gainers: Quoin Pharmaceuticals ( QNRX ) +45% . Evelo Biosciences ( EVLO ) +24% . Biodexa Pharmaceuticals ( BDRX ) +19% . LifeMD ( LFMD ) +13% . BIMI International Medical ( BIMI ) +12% . Losers: ...

QNRX - CLOV, EBS and PKX are among pre market gainers

2023-07-21 08:14:47 ET BioNexus Gene Lab Corp  ( BGLC ) +56% . Digital World Acquisition  ( DWAC ) +23% jumps 29% amid settlement with SEC. Guardforce AI ( GFAI ) +16% . Bragg Gaming Group  ( BRAG ) +13% . Emergent BioSolu...
QNRX - Why Is BridgeBio (BBIO) Stock Up 63% Today?

2023-07-17 10:04:34 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips BridgeBio Pharma (NASDAQ: BBIO ) stock is climbing higher on Monday as investors react to results from a Phase 3 clinical trial . These results come from the company...

QNRX - Why Is BYND Cannasoft Enterprise (BCAN) Stock Down 46% Today?

2023-07-17 08:28:17 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips BYND Cannasoft Enterprise (NASDAQ: BCAN ) stock is dropping on Monday after the company announced an underwritten stock offering . BYND Cannasoft announced the underwrit...

QNRX - Why Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today?

2023-07-17 08:18:38 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Quoin Pharmaceuticals (NASDAQ: QNRX ) stock is taking a massive beating on Monday as the company prepares for an ADS ratio change . According to a filing from Quoin Phar...
QNRX - APLS, QNRX and RNLX among pre-market losers

2023-07-17 08:16:34 ET Quoin Pharmaceuticals ( QNRX ) -91% . BYND Cannasoft Enterprises ( BCAN ) -47% . Apellis Pharmaceuticals ( APLS ) -33% . Baosheng Media Group Holdings Limited ( BAOS ) -13% . Ebix ( EBIX ) -11% after clarific...

QNRX - Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders

Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders NEW YORK, June 13, 2023 - (NewMediaWire) - PCG Digital--Lipella Pharmaceuticals (Nasdaq: LIPO) is a clinical-stage biotechnology company addressing serious di...

QNRX - Quoin Pharmaceuticals Announces 50% Enrollment in Open Label Netherton Syndrome Clinical Trial

ASHBURN, Va., May 24, 2023 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announces that its open label study evaluating QRX003 as a treat...
Previous 10 Next 10